Douglas Lazarus

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Julian Adams, Vito J. Palombella, Edward A. Sausville et al. · PubMed · 1999 · 1.5K citations

Proteasome Inhibitors, Effective Antitumor Agents, Proteasome +21

Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis

Vito J. Palombella, Elaine M. Conner, John W. Fuseler et al. · Proceedings of the National Academy of Sciences · 1998 · 285 citations

Endogenous IL-10 protects mice from death during septic peritonitis

Tom van der Poll, Arnaud Marchant, Wim A. Buurman et al. · The Journal of Immunology · 1995 · 284 citations

Cachexia and the acute‐phase protein response in inflammation are regulated by interleukin‐6

Hester S. A. Oldenburg, Michael A. Rogy, Douglas Lazarus et al. · European Journal of Immunology · 1993 · 154 citations

Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle

Scott Eliasof, Douglas Lazarus, Christian Peters et al. · Proceedings of the National Academy of Sciences · 2013 · 141 citations · Full text

Nanoparticles, Nanomedicine, Engineering +15